April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Natural Herbal Chemicals For Anti-angiogenesis In Eye
Author Affiliations & Notes
  • Vishal Jhanji
    Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Kowloon, Hong Kong
  • Huanming Liu
    Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Kowloon, Hong Kong
  • Kasin Law
    Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Kowloon, Hong Kong
  • Vincent Y. Lee
    Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Kowloon, Hong Kong
  • Shao-Fen Huang
    Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Kowloon, Hong Kong
  • Chi-Pui Pang
    Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Kowloon, Hong Kong
  • Gary H. Yam
    Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Kowloon, Hong Kong
  • Footnotes
    Commercial Relationships  Vishal Jhanji, None; Huanming Liu, None; Kasin Law, None; Vincent Y. Lee, None; Shao-Fen Huang, None; Chi-Pui Pang, None; Gary H. Yam, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4893. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Vishal Jhanji, Huanming Liu, Kasin Law, Vincent Y. Lee, Shao-Fen Huang, Chi-Pui Pang, Gary H. Yam; Natural Herbal Chemicals For Anti-angiogenesis In Eye. Invest. Ophthalmol. Vis. Sci. 2011;52(14):4893.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate the anti-angiogenic property of isoliquiritigenin by a systematic strategy of in vivo and in vitro models.

Methods: : Isoliquiritigenin (2-50 µM), Avastin (1 µg/ml) and vascular endothelial growth factor (VEGF, 100 ng/ml) were added to collagen-nylon mesh placed on chick chorioallantoic membrane (CAM) and the meshes with blood vessel ingrowth were quantified. Silver nitrate cauterization-induced corneal neovascularization in BALB/c mice was treated with topical ISL (0.2-50 µM) or balanced salt solution (BSS) 4 times daily and examined by immunostaining for CD31. Argon laser photocoagulation-induced choroidal neovascularization in C57BL/6 mice was treated by intravitreal isoliquiritigenin (10-200 µM), anti-VEGF monoclonal antibody or BSS and monitored by fundus fluorescein angiography. The severity of leakage was scored and choroid was immunostained with Griffonia simplicifolia isolectin-B4. Oxygen-induced retinopathy in C57BL/6J mouse pups was treated with intravitreal isoliquiritigenin (1-100 µM) or BSS, examined by isolectin-B4 staining and percentage of vascular area was quantified. The effect of ISL on VEGF signaling in human umbilical vein endothelial cells (HUVEC) was analyzed by western blotting.

Results: : Isoliquiritigenin dose-dependently suppressed VEGF-induced blood vessel growth in chick CAM. The progression of corneal neovascularization was suppressed by topical isoliquiritigenin (optimal dose at 10 µM and IC50 = 7.14 µM at day 7). Similarly, intravitreal isoliquiritigenin reduced choroidal and retinal neovascularisation. ISL down-regulated VEGF and up-regulated pigment epithelial growth factor expression in cultured HUVEC.

Conclusions: : Our results showed that isoliquiritigenin has anti-angiogenic properties probably mediated through pro- and anti-angiogenic factor levels.

Keywords: cornea: basic science • retinal neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×